Micromyx

Micromyx is a specialized contract research organization (CRO) focused on the discovery and development of new antimicrobial agents. Founded in 2004 by former Pharmacia/Upjohn microbiologists, the company provides a comprehensive suite of microbiology services, including antimicrobial susceptibility testing, mechanism of action studies, and in vivo infection models. In 2021, Micromyx was acquired by Charles River Laboratories, integrating its expertise into a larger global drug discovery portfolio. The company serves pharmaceutical and biotechnology clients by providing critical data for IND and NDA submissions for anti-infective candidates. Its laboratory facilities are located in Kalamazoo, Michigan, a historic hub for antibiotic research. Micromyx is recognized for its deep expertise in multi-drug resistant (MDR) pathogens and its ability to support programs from early discovery through clinical development.